Search

everythinglearnresearchcommunity

for

Search:↓

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Testosterone can both promote hair growth and cause baldness by affecting hair growth signals.

Wnt-3a helps grow more skin stem cells, which could lead to new hair loss treatments.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The model and estimator can predict drug exposure in kidney transplant patients well.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Thyroid hormones are important for skin health and changes in them can affect conditions like hair loss and eczema.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

The new gel combining calcipotriene and betamethasone is effective and safe for treating scalp psoriasis.

Hair loss in women may have multiple causes, and eyebrow regrowth possible with specific injections.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Vitamin D3 can help improve hair growth by enhancing the function of specific skin cells and could be useful in hair regeneration treatments.

The document concludes that there is a significant lack of reporting on the sex and age of cells in skin research, which could affect clinical trials and treatments.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

The article concludes that hair loss is a common side effect of drugs treating skin cancer by blocking the hedgehog pathway, but treatment should continue, and more selective drugs might prevent this side effect.

Finasteride improved symptoms in a schizophrenia patient.

Platelet-rich plasma might help with hair growth and skin conditions, but more research is needed to prove its effectiveness and safety.

Activating TRPV3 stops human hair growth.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

LGR5 helps maintain corneal cell characteristics and prevents unwanted changes by controlling specific cell signaling pathways.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

GMG-43AC may help reduce unwanted hair growth and treat certain hair loss conditions.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Estrogen and prolactin may play bigger roles in female hair loss than previously thought.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.